La Jolla, CA, United States of America

William Shirley

This inventor holds 1 USPTO granted patent. Top assignee: Cv Therapeutics, Inc.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Shirley. Retrieved from https://idiyas.com/inventor/william-shirley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William Shirley

Introduction

William Shirley is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of medical science, particularly in the area of cholesterol management. His work focuses on developing compounds that can have a profound impact on human health.

Latest Patents

William Shirley holds a patent for ABCA-1 elevating compounds. This invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of mammals, particularly humans. The compounds are useful for treating coronary artery disease, showcasing the potential of his research to improve cardiovascular health.

Career Highlights

Shirley is associated with Cv Therapeutics, Inc., where he continues to innovate and develop new therapeutic solutions. His work at the company reflects his commitment to advancing medical science and improving patient outcomes.

Collaborations

William Shirley has collaborated with notable professionals in his field, including Prabha N Ibrahim and Michael G Campbell. These collaborations highlight the importance of teamwork in driving innovation and achieving breakthroughs in research.

Conclusion

William Shirley's contributions to the field of medicine through his patent on ABCA-1 elevating compounds demonstrate his dedication to improving health outcomes. His work continues to inspire advancements in the treatment of coronary artery disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…